Redsense Medical AB Logo

Redsense Medical AB

Develops FDA/CE-marked blood loss alarms for hemodialysis using fiber optic tech for EU/US markets.

REDS | SPGR

Overview

Corporate Details

ISIN(s):
SE0006965158
LEI:
549300J0ML1B5HLS7182
Country:
Sweden
Address:
Box 7088, 300 07 Halmstad
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Redsense Medical AB is a medical technology company specializing in the development of blood loss detection systems for medical treatments. The company's core product is an alarm system designed to monitor blood access during hemodialysis, using patented fiber optic technology to provide an early warning for venous needle dislodgement. The Redsense system is the only blood loss detection alarm that is both FDA-cleared and CE-marked for any mode of hemodialysis. Primarily serving markets in Europe and the United States, the company is also developing AI-driven wound monitoring software to expand its patient safety solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Redsense Medical AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Redsense Medical AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Redsense Medical AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-03 Sebastien Bollue Other Buy 7,000 53,900.00 SEK
2024-10-02 Sebastien Bollue Other Buy 6,000 45,180.00 SEK
2024-09-24 Susanne Olausson Other Buy 10,000 66,458.80 SEK

Peer Companies

Company Country Ticker View
Pulmonx Corp Logo
Offers minimally invasive valves to treat severe emphysema/COPD and improve breathing.
United States of America LUNG
PULSE BIOSCIENCES, INC. Logo
Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.
United States of America PLSE
Qiagen N.V. Logo
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands QIA
QIAGEN N.V. Logo
Develops sample-to-insight tech for molecular diagnostics, research, and pharma applications.
United States of America QGEN
QLife Holding AB Logo
Develops an at-home IVD platform for biomarker and virus testing from blood samples.
Sweden QLIFE
IVD specialist in rapid antimicrobial susceptibility testing for critical infections like sepsis.
South Korea 317690
Quanterix Corp Logo
Offers an ultra-sensitive immunoassay platform for biomarker analysis in research and diagnostics.
United States of America QTRX
Raphas Co., Ltd. Logo
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea 214260
RenovoRx, Inc. Logo
Develops a device platform for delivering targeted therapies directly to solid tumors.
United States of America RNXT
RESMED INC Logo
Develops cloud-connected medical devices and software for sleep apnea and respiratory care.
United States of America RMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.